United States· US:0187-0004_52e758a5-e5b3-954f-e063-6394a90afac0
Siliq
A medicinal product containing brodalumab, registered in United States by Bausch Health US LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Brodalumab
- Manufacturer
- Bausch Health US LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 3
- ndc1101870004022 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00)
- ndc1101870004032 INJECTION in 1 CARTON (0187-0004-03)
- ndc1101870004041 INJECTION in 1 SYRINGE (0187-0004-04)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brodalumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- Japanブロダルマブ（遺伝子組換え）協和キリン
- CzechiaKYNTHEUMLEO Pharma A/S, Ballerup
- SpainKYNTHEUM 210 MG SOLUCION INYECTABLE EN JERINGA PRECARGADALeo Pharma A/S
- FinlandKyntheumLeo Pharma A/S
- FranceKYNTHEUM 210 mg, solution injectable en seringue préremplieLEO PHARMA A/S (DANEMARK)
- United KingdomKyntheum 210mg/1.5ml solution for injection pre-filled syringesLEO Pharma
- IrelandKyntheum 210 mg solution for injection in pre-filled syringeLEO Pharma A/S
- IcelandKyntheumLEO Pharma A/S*
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Kyntheum
- Iceland · Kyntheum
- Liechtenstein · Kyntheum
- Norway · Kyntheum
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/054bb62a-0f66-4c14-a0c6-edf1aa4aae48 GET /v1/drugs/054bb62a-0f66-4c14-a0c6-edf1aa4aae48?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"productid": "0187-0004_52e758a5-e5b3-954f-e063-6394a90afac0",
"productndc": "0187-0004",
"dosage_form": "INJECTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "BRODALUMAB",
"proprietary_name": "Siliq",
"active_ingred_unit": "mg/1",
"application_number": "BLA761032",
"marketing_category": "BLA",
"nonproprietary_name": "Brodalumab",
"start_marketing_date": "20170215",
"active_numerator_strength": "210"
}See everything about brodalumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.